LUP Statistics
Record
- Title
- Development and preclinical assessment of novel therapies for Epilepsy. Exploring the potential of human-derived cell lines and glial cell line-derived neurotrophic factor for network inhibition.
- Type
- Dissertation
- Publ. year
- 2022
- Author/s
- Waloschkova, Eliska
- Department/s
- Epilepsy Center; Experimental Epilepsy Group
- In LUP since
- 2022-03-31
Downloads
| Total | This Year | This Month |
| 169 | 10 | 1 |
Sweden  |
34 (20%) |
United States of America  |
29 (17%) |
Finland  |
23 (14%) |
Russian Federation  |
13 (8%) |
China  |
9 (5%) |
France  |
8 (5%) |
India  |
7 (4%) |
Czechia  |
7 (4%) |
Unknown  |
7 (4%) |
Singapore  |
4 (2%) |
Ireland  |
3 (2%) |
Austria  |
3 (2%) |
Hong Kong (China)  |
3 (2%) |
South Korea  |
2 (1%) |
Turkiye  |
2 (1%) |
Indonesia  |
2 (1%) |
Brazil  |
2 (1%) |
Germany  |
2 (1%) |
Pakistan  |
1 (1%) |
Denmark  |
1 (1%) |
Italy  |
1 (1%) |
Canada  |
1 (1%) |
Bangladesh  |
1 (1%) |
Ghana  |
1 (1%) |
Saudi Arabia  |
1 (1%) |
Spain  |
1 (1%) |
Greece  |
1 (1%) |